What's it like to be a doctor treating patients with phage therapy in the US today?

Dr. Gina Suh, Mayo Clinic infectious disease physician, tells us:

- How she established phage therapy as an option for her patients at Mayo

- How phages have helped her patients

- What's been hardest

- Where she's hopeful

- Where things have gotten worse

- What's next

This episode, I'm joined by my phage friend Joe Campbell (former NIH program officer)!

This is part 1 of a series we'll be co-hosting together, digging into phage therapy from multiple perspectives, trying to answer our curiosities about what's holding phage therapy back in this country and beyond — stay tuned! 

Chapters

00:00 Introduction to our new phage therapy series

01:23 Dr. Gina Suh's journey into phage therapy

06:01 How Gina has shifted how she selects patients for phage therapy

14:35 Challenges Gina has faced with phage therapy

17:46 Research needs: what the field should be studying

26:16 Infrastructure needs: Gina's wishlist

44:34 Gina's phage therapy aspirations

55:18 Why are there no support groups for antibiotic resistance?

Watch this episode on YouTube: https://youtu.be/b2NBYn4jEUo

Learn more: 

Paper by Gina and team: Considerations for the use of phage therapy in clinical practice: https://pubmed.ncbi.nlm.nih.gov/35041506/

Video: Gina Suh and John Haverty talk about John's treatment with phages (2021): https://youtu.be/XZPLt6wkh5A?si=PxSZAYmOkn2KICLs